Bone Biologics Corp Warrants
BBLGW
2 hedge funds and large institutions have $1.82M invested in Bone Biologics Corp Warrants in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.82% less ownership
Funds ownership: 3.6% → 2.79% (-0.82%)
10% less capital invested
Capital invested by funds: $2.02M → $1.82M (-$203K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2.68K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$603 |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$78 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $1.82M | -$603 | -9 | -0% |
|
|
2
UBS Group
Zurich,
Switzerland
| $46 | +$2.68K | +40 | New |
|
|
3
Bank of America
Charlotte,
North Carolina
| – | -$78 | -7 | Closed |
|
BBLGW Hedge Fund Activity: Q3 2024 in Review
2 of the 6,967 institutional investors tracked by Wall St. Rank reported a position in Bone Biologics Corp Warrants (BBLGW) for Q3 2024, worth a combined $1.82M — down 10% from $2.02M a quarter earlier.
Fund positioning in BBLGW was balanced in Q3 2024: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $2.68K. The largest seller was Citadel Advisors, cutting an estimated $603.
- 2 institutional investors held Bone Biologics Corp Warrants (BBLGW) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $1.82M of Bone Biologics Corp Warrants stock for Q3 2024, down 10% quarter-over-quarter.
- 1 fund opened new Bone Biologics Corp Warrants positions in Q3 2024 and 1 closed out, a net change of 0 holders.
- The largest Bone Biologics Corp Warrants buyer in Q3 2024 was UBS Group, an estimated $2.68K added.
- The largest Bone Biologics Corp Warrants seller in Q3 2024 was Citadel Advisors, an estimated $603 sold.
Based on aggregated 13F filings for Q3 2024.